Verus Capital Partners’s Hologic HOLX Stock Holding History

Verus Capital Partners’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-300	Closed	-$16K	–	1533
2019 Q4	$16K	Buy	+300	New	+$14.9K	0.01%	971

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Verus Capital Partners's HOLX Position: Q1 2020 in Review

Verus Capital Partners sold out of Hologic (HOLX) in Q1 2020, closing a stake of 300 shares — an estimated $16K sold.

Verus Capital Partners first reported a position in HOLX in Q4 2019 and held it in 1 quarter. The position peaked at $16K in Q4 2019. 485 funds tracked by Wall St. Rank hold HOLX as of Q1 2020.

Verus Capital Partners reported no remaining Hologic position as of Q1 2020 after selling out during the quarter.
Verus Capital Partners sold 300 Hologic shares in Q1 2020, an estimated $16K.
Verus Capital Partners first reported a position in Hologic in Q4 2019 and held it in 1 quarter.
Verus Capital Partners's Hologic position peaked at $16K in Q4 2019.
485 funds tracked by Wall St. Rank held Hologic as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.